This product is a live Clostridium butyricum (spore) preparation, which can tolerate gastric acid entering the intestine, secrete butyric acid (butyric acid), an important nutrient for intestinal mucosal regeneration and repair, repair damaged intestinal mucosa, eliminate inflammation, and nourish the intestine. It can also promote the growth of beneficial intestinal bacteria such as Bifidobacterium, inhibit the growth of harmful intestinal bacteria such as Shigella dysenteriae, restore the balance of intestinal flora, reduce the production of intestinal toxins such as amines, ammonia, and indoles, and their toxicity to intestinal mucosa, and restore intestinal immune function and normal physiological function. It has a significant therapeutic effect on rat immune ulcerative colitis, inhibits the excessive and abnormal expression of inflammatory factors such as IL-8 and TNF-α, inhibits the excessive expression of anti-colon antibody IgG, reduces the transformation rate of B lymphocytes, increases the transformation rate of T lymphocytes, corrects intestinal immune disorders, restores intestinal immune tolerance, eliminates inflammation and ulcers, and effectively treats ulcerative colitis. At the same time, Clostridium butyricum produces enzymes and vitamins in the intestine to promote the digestion and absorption of nutrients.

It can tolerate gastric acid entering the intestine, secrete butyric acid (butyric acid), an important nutrient for intestinal mucosal regeneration and repair, repair damaged intestinal mucosa, eliminate inflammation, and nourish the intestine. It promotes the growth of beneficial intestinal bacteria such as bifidobacteria, inhibits the growth of harmful intestinal bacteria such as Shigella dysenteriae, restores the balance of intestinal flora, reduces the production of intestinal toxins such as amines, ammonia, and indoles, and their toxicity to intestinal mucosa, and restores intestinal immune function and normal physiological function. It has a significant therapeutic effect on rat immune ulcerative colitis, can inhibit the excessive and abnormal expression of inflammatory factors such as IL-8 and TNF-α, inhibit the excessive expression of anti-colon antibody IgG, reduce the transformation rate of B lymphocytes, increase the transformation rate of T lymphocytes, correct intestinal immune disorders, restore intestinal immune tolerance, eliminate inflammation and ulcers, and effectively treat ulcerative colitis. At the same time, it produces enzymes and vitamins in the intestine to promote the digestion and absorption of nutrients.

This product is a live Clostridium butyricum (spore) preparation, which can tolerate gastric acid entering the intestine, secrete butyric acid (butyric acid), an important nutrient for intestinal mucosal regeneration and repair, repair damaged intestinal mucosa, eliminate inflammation, and nourish the intestine. It can also promote the growth of beneficial intestinal bacteria such as Bifidobacterium, inhibit the growth of harmful intestinal bacteria such as Shigella dysenteriae, restore the balance of intestinal flora, reduce the production of intestinal toxins such as amines, ammonia, and indoles, and their toxicity to intestinal mucosa, and restore intestinal immune function and normal physiological function. This product has a significant therapeutic effect on rat immune ulcerative colitis, inhibits the excessive and abnormal expression of inflammatory factors such as IL-8 and TNF-α, inhibits the excessive expression of anti-colon antibody IgG, reduces the transformation rate of B lymphocytes, increases the transformation rate of T lymphocytes, corrects intestinal immune disorders, restores intestinal immune tolerance, eliminates inflammation and ulcers, and effectively treats ulcerative colitis. At the same time, Clostridium butyricum produces enzymes and vitamins in the intestine to promote the digestion and absorption of nutrients.

This product is a live Clostridium butyricum (spore) preparation, which can tolerate gastric acid entering the intestine, secrete butyric acid (butyric acid), an important nutrient for intestinal mucosal regeneration and repair, repair damaged intestinal mucosa, eliminate inflammation, and nourish the intestine. It can also promote the growth of beneficial intestinal bacteria such as Bifidobacterium, inhibit the growth of harmful intestinal bacteria such as Shigella dysenteriae, restore the balance of intestinal flora, reduce the production of intestinal toxins such as amines, ammonia, and indoles, and their toxicity to intestinal mucosa, and restore intestinal immune function and normal physiological function. This product has a significant therapeutic effect on rat immune ulcerative colitis, inhibits the excessive and abnormal expression of inflammatory factors such as IL-8 and TNF-α, inhibits the excessive expression of anti-colon antibody IgG, reduces the transformation rate of B lymphocytes, increases the transformation rate of T lymphocytes, corrects intestinal immune disorders, restores intestinal immune tolerance, eliminates inflammation and ulcers, and effectively treats ulcerative colitis. At the same time, Clostridium butyricum produces enzymes and vitamins in the intestine to promote the digestion and absorption of nutrients.

It can tolerate gastric acid entering the intestine, secrete butyric acid (butyric acid), an important nutrient for intestinal mucosal regeneration and repair, repair damaged intestinal mucosa, eliminate inflammation, and nourish the intestine. It promotes the growth of beneficial intestinal bacteria such as bifidobacteria, inhibits the growth of harmful intestinal bacteria such as Shigella dysenteriae, restores the balance of intestinal flora, reduces the production of intestinal toxins such as amines, ammonia, and indoles, and their toxicity to intestinal mucosa, and restores intestinal immune function and normal physiological function. It has a significant therapeutic effect on rat immune ulcerative colitis, can inhibit the excessive and abnormal expression of inflammatory factors such as IL-8 and TNF-α, inhibit the excessive expression of anti-colon antibody IgG, reduce the transformation rate of B lymphocytes, increase the transformation rate of T lymphocytes, correct intestinal immune disorders, restore intestinal immune tolerance, eliminate inflammation and ulcers, and effectively treat ulcerative colitis. At the same time, it produces enzymes and vitamins in the intestine to promote the digestion and absorption of nutrients.

This product is a live Clostridium butyricum (spore) preparation, which can tolerate gastric acid entering the intestine, secrete butyric acid (butyric acid), an important nutrient for intestinal mucosal regeneration and repair, repair damaged intestinal mucosa, eliminate inflammation, and nourish the intestine. It can also promote the growth of beneficial intestinal bacteria such as Bifidobacterium, inhibit the growth of harmful intestinal bacteria such as Shigella dysenteriae, restore the balance of intestinal flora, reduce the production of intestinal toxins such as amines, ammonia, and indoles, and their toxicity to intestinal mucosa, and restore intestinal immune function and normal physiological function. This product has a significant therapeutic effect on rat immune ulcerative colitis, inhibits the excessive and abnormal expression of inflammatory factors such as IL-8 and TNF-α, inhibits the excessive expression of anti-colon antibody IgG, reduces the transformation rate of B lymphocytes, increases the transformation rate of T lymphocytes, corrects intestinal immune disorders, restores intestinal immune tolerance, eliminates inflammation and ulcers, and effectively treats ulcerative colitis. At the same time, Clostridium butyricum produces enzymes and vitamins in the intestine to promote the digestion and absorption of nutrients.

This product is a live Clostridium butyricum (spore) preparation, which can tolerate gastric acid entering the intestine, secrete butyric acid (butyric acid), an important nutrient for intestinal mucosal regeneration and repair, repair damaged intestinal mucosa, eliminate inflammation, and nourish the intestine. It can also promote the growth of beneficial intestinal bacteria such as Bifidobacterium, inhibit the growth of harmful intestinal bacteria such as Shigella dysenteriae, restore the balance of intestinal flora, reduce the production of intestinal toxins such as amines, ammonia, and indoles, and their toxicity to intestinal mucosa, and restore intestinal immune function and normal physiological function. This product has a significant therapeutic effect on rat immune ulcerative colitis, inhibits the excessive and abnormal expression of inflammatory factors such as IL-8 and TNF-α, inhibits the excessive expression of anti-colon antibody IgG, reduces the transformation rate of B lymphocytes, increases the transformation rate of T lymphocytes, corrects intestinal immune disorders, restores intestinal immune tolerance, eliminates inflammation and ulcers, and effectively treats ulcerative colitis. At the same time, Clostridium butyricum produces enzymes and vitamins in the intestine to promote the digestion and absorption of nutrients.

This product is a live Clostridium butyricum (spore) preparation, which can tolerate gastric acid entering the intestine, secrete butyric acid (butyric acid), an important nutrient for intestinal mucosal regeneration and repair, repair damaged intestinal mucosa, eliminate inflammation, and nourish the intestine. It can also promote the growth of beneficial intestinal bacteria such as Bifidobacterium, inhibit the growth of harmful intestinal bacteria such as Shigella dysenteriae, restore the balance of intestinal flora, reduce the production of intestinal toxins such as amines, ammonia, and indoles, and their toxicity to intestinal mucosa, and restore intestinal immune function and normal physiological function. This product has a significant therapeutic effect on rat immune ulcerative colitis, inhibits the excessive and abnormal expression of inflammatory factors such as IL-8 and TNF-α, inhibits the excessive expression of anti-colon antibody IgG, reduces the transformation rate of B lymphocytes, increases the transformation rate of T lymphocytes, corrects intestinal immune disorders, restores intestinal immune tolerance, eliminates inflammation and ulcers, and effectively treats ulcerative colitis. At the same time, Clostridium butyricum produces enzymes and vitamins in the intestine to promote the digestion and absorption of nutrients.

This product is a live Clostridium butyricum (spore) preparation, which can tolerate gastric acid entering the intestine, secrete butyric acid (butyric acid), an important nutrient for intestinal mucosal regeneration and repair, repair damaged intestinal mucosa, eliminate inflammation, and nourish the intestine. It can also promote the growth of beneficial intestinal bacteria such as Bifidobacterium, inhibit the growth of harmful intestinal bacteria such as Shigella dysenteriae, restore the balance of intestinal flora, reduce the production of intestinal toxins such as amines, ammonia, and indoles, and their toxicity to intestinal mucosa, and restore intestinal immune function and normal physiological function. This product has a significant therapeutic effect on rat immune ulcerative colitis, inhibits the excessive and abnormal expression of inflammatory factors such as IL-8 and TNF-α, inhibits the excessive expression of anti-colon antibody IgG, reduces the transformation rate of B lymphocytes, increases the transformation rate of T lymphocytes, corrects intestinal immune disorders, restores intestinal immune tolerance, eliminates inflammation and ulcers, and effectively treats ulcerative colitis. At the same time, Clostridium butyricum produces enzymes and vitamins in the intestine to promote the digestion and absorption of nutrients.

It has an antidiarrheal effect on diarrhea in mice caused by ampicillin, a laxative effect on constipation in mice induced by compound diphenoxylate, and a significant anti-inflammatory therapeutic effect on experimental ulcerative colitis in rats induced by dextran sodium sulfate. In vitro tests show that it has an inhibitory effect on the growth of Escherichia coli, Salmonella typhi, Proteus vulgaris, Pseudomonas aeruginosa, Staphylococcus aureus and Shigella dysenteriae.